Lonapegsomatropin Uses, Dosage, Side Effects and more
Lonapegsomatropin is under investigation in clinical trial NCT04615273 (A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency).
| Trade Name | Lonapegsomatropin |
| Availability | Prescription only |
| Generic | Lonapegsomatropin |
| Lonapegsomatropin Other Names | Lonapegsomatropin, Rhgh-peg, Transconpeg hgh, Transconpeg-hgh |
| Related Drugs | Genotropin, Norditropin, somatropin, Skytrofa, Humatrope, Norditropin FlexPro |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Disease Interaction
Major: active malignancy, acute critical illness, Prader-Willi SyndromeModerate: diabetes, hypothyroidism
